Research protocols typically start at 2550mg daily for tolerance assessment, then escalate to 50100mg based on individual response and objective metabolic markers
Chetna Bakshi, M.D., a bariatric surgeon at Northwell Healths Syosset Hospital in New York, says patients who have medullary thyroid cancer or a family history of it should not take them, because of the potential risk of thyroid C-cell tumors
However, there are situations where the needs increase or the intake decreases : intense exercise, aging or diets with little animal protein (like vegetarian or vegan) are the most common
furthermore, the potentially beneficial effects could be sought
An analysis of the FDA's adverse event database found that semaglutide (Ozempic) had the highest odds ratio for reporting constipation among GLP-1 medications
Conclusion In conclusion, while semaglutide may lead to temporary hair loss for some individuals, it is not a widespread or permanent side effect